Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 369, Issue 1, pp 1–22

β-Adrenoceptor polymorphisms

  • K. Leineweber
  • R. Büscher
  • H. Bruck
  • O.-E. Brodde


There can be no doubt that β1-, β2- and β3-adrenoceptor genes have genetic polymorphisms. Two single nucleotide polymorphisms have been described for the β1- (Ser49Gly; Gly389Arg), three for the β2- (Arg16Gly; Gln27Glu; Thr164Ile) and one for the β3-adrenoceptor subtype (Trp64Arg) that might be of functional importance. The possibility that changes in expression or properties of the β-adrenoceptors due to single nucleotide polymorphisms might have phenotypic consequences influencing their cardiovascular or metabolic function or may contribute to the pathophysiology of several disorders like hypertension, congestive heart failure, asthma or obesity is an idea that has attracted much interest during the last 10 years. At present, it appears that these β-adrenoceptor polymorphisms are very likely not disease-causing genes, but might be risk factors, might modify disease and/or might influence progression of disease. The aim of this review is to provide an overview of the functional consequences of such β-adrenoceptor polymorphisms in vitro, ex vivo and in vivo.


β-Adrenoceptors Single nucleotide polymorphism Linkage disequilibrium Genotype Haplotype Phenotype 


  1. Allison DB, Heo M, Faith MS, Pietrobelli A (1998) Meta-analysis of the association of the Trp64Arg polymorphism in the β3 adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 22:559–566PubMedGoogle Scholar
  2. Anthony A, Schepelmann S, Guillaume JL, Strosberg AD, Dhillon AP, Pounder RE, Wakefield AJ (1998) Localization of the β3-adrenoceptor in the human gastrointestinal tract: an immunohistochemical study. Aliment Pharmacol Ther 12:519–525CrossRefPubMedGoogle Scholar
  3. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S (1984) Atypical adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163–165PubMedGoogle Scholar
  4. Arner P, Hoffstedt J (1999) Adrenoceptor genes in human obesity. J Intern Med 245:667–672Google Scholar
  5. Aynacioglu AS, Cascorbi I, Güngör K, Özkur M, Bekir N, Roots I, Brockmöller J (1999) Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the β2-adrenergic receptor among Turks. Brit J Clin Pharmacol 48:761–764CrossRefGoogle Scholar
  6. Aziz I, Hall IP, McFarlane LC, Lipworth BJ (1998) Beta 2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. J Allergy Clin Immunol 101:337–341PubMedGoogle Scholar
  7. Baba T, Nakajima S, Yajima Y (1998) β3-adrenergic receptor gene polymorphism is not associated with hypertension in NIDDM patients without nephropathy. Horm Metab Res 30:629–632PubMedGoogle Scholar
  8. Barbato E, Penicka M, Delrue L, Vanderheyden M, Wijns, Heyndrickx G, Goethals M, De Bruyne B, Bartunek J (2002) Genetic modulation of human cardiac performance by Ile-164 polymorphism of beta-2 adrenergic receptor. Circulation 106 No 19 (Suppl II):327–328Google Scholar
  9. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Råstam L, Groop L (2001a) Polymorphisms in the β1-adrenergic receptor gene and hypertension. Circulation 104:187–190PubMedGoogle Scholar
  10. Bengtsson K, Orho-Melander M, Melander O, Lindblad U, Ranstam J, Råstam L, Groop L (2001b) β2-Adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 37:1303–1308PubMedGoogle Scholar
  11. Berkowitz DE, Nardone NA, Smiley RM, Price DT, Kreutter DK, Fremeau RT, Schwinn DA (1995) Distribution of b3-adrenoceptor mRNA in human tissue. Eur J Pharmacol 289:223–228CrossRefPubMedGoogle Scholar
  12. Börjesson M, Magnusson Y, Hjalmarson A, Andersson B (2000) A novel polymorphism in the gene coding for the beta1-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 21:1853–1858CrossRefPubMedGoogle Scholar
  13. Bray MS, Krushkal J, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E (2000) Positional genomic analysis identifies the β2-adrenergic receptor gene as susceptible locus for human hypertension. Circulation 101:2877–2882PubMedGoogle Scholar
  14. Brodde O-E (1991) β1- and β2-adrenoceptors in the human heart: properties, function, and alterations in heart failure. Pharmacol Rev 43:203–242PubMedGoogle Scholar
  15. Brodde O-E, Michel MC (1999) Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51:651–689PubMedGoogle Scholar
  16. Brodde O-E, Büscher R, Tellkamp R, Radke J, Dhein S, Insel PA (2001) Blunted cardiac responses to receptor activation in subjects with Thr164Ile β2-adrenoceptors. Circulation 103:1048–1050Google Scholar
  17. Bruck H, Leineweber K, Büscher R, Ulrich A, Radke J, Insel PA, Brodde O-E (2003a) The Gln27Glu β2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo. Pharmacogenetics 13:59–66CrossRefPubMedGoogle Scholar
  18. Bruck H, Leineweber K, Ulrich A, Radke J, Heusch G, Philipp T, Brodde O-E (2003b) The Thr164Ile polymorphism of the human β2-adrenoceptor exhibits blunted desensitization of cardiac functional responses in vivo. Am J Physiol Heart Circ Physiol 285:H2034–H2038Google Scholar
  19. Bruck H, Leineweber K, Beilfuß A, Weber M., Heusch G, Philipp T, Brodde O-E (2003c) Genotype-dependent time course of lymphocyte β2-adrenergic receptor down-regulation. Clin Pharmacol Ther 74:255–263Google Scholar
  20. Büscher R, Belger H, Eilmes KJ, Tellkamp R, Radke J, Dhein S, Hoyer PF, Michel MC, Insel PA, Brodde O-E (2001) In-vivo studies do not support a major functional role for the Gly389Arg β1-adrenoceptor polymorphism in humans. Pharmacogenetics 11:199–205CrossRefPubMedGoogle Scholar
  21. Büscher R, Eilmes KJ, Grasemann H, Torres B, Knauer N, Sroka K, Insel PA, Ratjen F (2002) β2 Adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics 12:347–353CrossRefPubMedGoogle Scholar
  22. Busjahn A, Li G-H, Faulhaber H-D, Rosenthal M, Becker A, Jeschke E, Schuster H, Timmermann B, Hoehe MR, Luft FC (2000) β2-Adrenergic receptor gene variations, blood pressure, and heart size in normal twins. Hypertension 35:555–560PubMedGoogle Scholar
  23. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) IV. International Union of Pharmacology: nomenclature of adrenoceptors. Pharmacol Rev 46:212–136Google Scholar
  24. Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader CD (1996) Pharmacological characterization of a recently described human β3-adrenergic receptor mutant. Endocrinology 137:2638–2641PubMedGoogle Scholar
  25. Candy G, Samani N, Norton G, Woodiwiss A, Radevski I, Wheatly A, Cockcroft J, Hall IP (2000) Association analysis of β2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens 18:167–172PubMedGoogle Scholar
  26. Carlsson M, Orho-Melander M, Hedenbro J, Groop LC (2001) Common variants in the β2- (Gln27Glu) and β3- (Trp64Arg)-adrenoceptor genes are associated with elevated serum NEFA concentrations and Type II diabetes. Diabetologia 44:629–636CrossRefPubMedGoogle Scholar
  27. Chamberlain PD, Jennings KH, Paul F, Cordell J, Berry A, Holmes SD, Park J; Chambers J, Sennitt MV, Stock MJ, Cawthorne MA, Young PW, Murphy GJ (1999) The tissue distribution of the human β3-adrenoceptor studied using a monoclonal antibody: direct evidence of the β3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 23:1057–1065CrossRefPubMedGoogle Scholar
  28. Charon C, Dupuy F, Marie V, Bazin R (1995a) Effect of the β-adrenoceptor agonist BRL-35135 on development of obesity in suckling Zucker (fa/fa) rats. Am J Physiol 268:E1039–E1045PubMedGoogle Scholar
  29. Charon C, Krief S, Diot-Dupuy F, Strosberg AD, Emorine LJ, Bazin R (1995b) Early alterations in the brown adipose tissue adenylate cyclase system of pre-obese Zucker rat fa/fa pups: decreased G-proteins and β3-adrenoceptor activities. Biochem J 312:781–788PubMedGoogle Scholar
  30. Chen Y, Xu Y, Zhou L (2001) Association of β3-adrenergic receptor gene with obesity in patients with type 2 diabetes mellitus. Zhonghua Yu Fang Yi Xue Za Zhi 35:333–335PubMedGoogle Scholar
  31. Chong LK, Chowdry J, Ghahramani P, Peachell PT (2000) Influence of genetic polymorphisms in the [beta]2-adrenoceptor on desensitisation in human lung mast cells. Pharmacogenetics 10:153–162CrossRefPubMedGoogle Scholar
  32. Christiansen C, Poulsen P, Beck-Nielsen H (1999) The Trp64Arg mutation of the adrenergic β3 receptor gene impairs insulin secretion: a twin study. Diabet Med 16:835–840CrossRefPubMedGoogle Scholar
  33. Clément K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg AD (1995) Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352–354PubMedGoogle Scholar
  34. Cockroft JR, Gazis AG, Cross DJ, Wheatley A, Dewar J, Hall IP, Noon JP (2000) β2-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 36:371–375PubMedGoogle Scholar
  35. Collins S, Daniel KW, Rohlfs EM (1999) Depressed expression of adipocyte β-adrenergic receptors is a common feature of congenital and diet-induced obesity in rodents. Int J Obes Relat Metab Disord 23:669–677CrossRefPubMedGoogle Scholar
  36. D’Amato M, Vitiani LR, Petrelli G, Ferrigno L, Pietro AD, Trezza R, Matricardi PM (1998) Association of persistent bronchial hyperresponsiveness with β2-adrenoceptor (ADRB2) haplotypes. Am J Respir Crit Care Med 158:1968–1973PubMedGoogle Scholar
  37. Deichmann KA, Schmidt A, Heinzmann A, Kruse S, Forster J, Kuehr J (1999) Association studies on β2-adrenoceptor polymorphisms and enhanced IgE responsiveness in an atopic population. Clin Exp All 29:794–799PubMedGoogle Scholar
  38. Dewar JC, Wilkinson J, Wheatley A, Thomas NS, Doull I, Morton N, Lio P, Harvey J, Liggett SB, Holgate S, Hall IP (1997) The glutamine 27 β2 adrenoceptor polymorphism is associated with elevated immunglobulin E levels in asthmatic families. J Allergy Clin Immunol 100:261–265PubMedGoogle Scholar
  39. Dewar JC, Wheatley AP, Venn A, Morrison JFJ, Britton J, Hall IP (1998) β2 Adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clin Exp All 28:442–448CrossRefPubMedGoogle Scholar
  40. Dishy V, Sofowora G, Xie HG, Harris P, Wood AJJ Stein CM (2001a) Arg389Gly beta-1 adrenoceptor polymorphism does not affect agonist-mediated responses in vivo (abstract). Clin Pharmacol Ther 69:P5Google Scholar
  41. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ (2001b) The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345:1030–1035Google Scholar
  42. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB (2000) Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 97:10483–10488CrossRefPubMedGoogle Scholar
  43. Echwald SM, Sorensen TI, Tybjaerg-HansenA, Andersen T, Pedersen O (1998) Gln27Glu variant of the human beta2-adrenoceptor gene is not associated with early-onset obesity in Danish men. Diabetes 47:1657–1658PubMedGoogle Scholar
  44. Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, Strosberg AD (1989) Molecular characterization of the human β3-adrenergic receptor. Science 245:1118–1121PubMedGoogle Scholar
  45. Evans BA, Papaioannou M, Bonazzi VR, Summers RJ (1996) Expression of β3-adrenoceptor mRNA in rat tissues. Br J Pharmacol 117:210–216PubMedGoogle Scholar
  46. Fenech A, Hall IP (2001) Pharmacogenetics of asthma. Br J Clin Pharmacol 53:3–15CrossRefGoogle Scholar
  47. Frielle T, Collins S, Daniel KW, Caron MG, Lefkowitz RJ, Kobilka BK (1987) Cloning of the cDNA for the human β1-adrenergic receptor. Proc Natl Acad Sci USA 84:7920–7924PubMedGoogle Scholar
  48. Fujisawa T, Ikegami H, Yamato E, Hamada Y, Kamide K, Rakugi H, Higaki J, Murakami H, Shimamoto K, Ogihara T (1997) Trp64Arg mutation of β3-adrenergic receptor in essential hypertension: insulin resistance and the adrenergic system. Am J Hypertens 10:101–105CrossRefPubMedGoogle Scholar
  49. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T (1998) Meta-analysis of the association of Trp64Arg polymorphism of β3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 83:2441–2444PubMedGoogle Scholar
  50. Garovic VD, Joyner MJ, Dietz NM, Boerwinkle E, Turner ST (2003) β2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol (Lond) 546:583–589Google Scholar
  51. Gauthier C, Tavernier G, Charpentier F, Langin D, LeMarec H (1996) Functional β3-adrenoceptor in the human heart. J Clin Invest 98:556–562PubMedGoogle Scholar
  52. Gauthier C, Langin D, Balligand JL (2000) β3-Adrenoceptors in the cardiovascular system. Trends Pharmacol Sci 21:426–431CrossRefPubMedGoogle Scholar
  53. Granneman JG (1995) Expression of adenylyl cyclase subtypes in brown adipose tissue: neuronal regulation of type III. Endocrinol 136:2007–2012Google Scholar
  54. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft FC, Hoehe MR, Skrabal F (1999) Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 33:1425–1430PubMedGoogle Scholar
  55. Green SA, Cole G, Jacinto M, Innes M, Liggett SB (1993) A polymorphism of the human β2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268:23116–23121PubMedGoogle Scholar
  56. Green SA, Turki J, Innes M, Liggett SB (1994) Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414–9419PubMedGoogle Scholar
  57. Green SA, Turki J, Hall IP, Liggett SB (1995a) Implications of genetic variability of human β2-adrenergic receptor structure. Pulm Pharmacol 8:1–10CrossRefPubMedGoogle Scholar
  58. Green SA, Turki J, Bejarano P, Hall IP, Liggett SB (1995b) Influence of β2-adrenergic receptor genotype on signal transduction in human airway muscle cells. Am J Respir Cell Mol Biol 13:25–33PubMedGoogle Scholar
  59. Green SA, Rathz DA, Schuster AJ, Liggett SB (2001) The Ile164 β2-adrenoceptor polymorphism alters salmoterol exosite binding and conventional agonist coupling to Gs. Eur J Pharmacol 421:141–147CrossRefPubMedGoogle Scholar
  60. Guillaume JL, Petitjean F, Haasemann M, Bianchi C, Eshdat Y, Strosberg AD (1994) Antibodies for the immunochemistry of the human β3-adrenergic receptor. Eur J Biochem 224:761–770PubMedGoogle Scholar
  61. Hall IP, Wheatley A, Wilding P, Liggett SB (1995) Association of the Glu27 β2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345:1213–1214PubMedGoogle Scholar
  62. Hancox RJ, Sears MR, Taylor DR (1998) Polymorphism of the β2-adrenoceptor and the response to long-term β2-agonist therapy in asthma. Eur Respir J 100:3184–3188Google Scholar
  63. Harris P, Stein CM (2001) Arg389Gly beta1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 11:191–197CrossRefPubMedGoogle Scholar
  64. Heckbert SR, Hindorff LA, Edwards KL, Psaty BM, Lumley T, Siscovick DS, Tang Z, Durda JP, Kronmal RA, Tracy RP (2003) β2-Adrenergic receptor polymorphism and risk of incident cardiovascular events in the elderly. Circulation 107:2021–2024CrossRefPubMedGoogle Scholar
  65. Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P (1999) The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and females. J Intern Med 245:253–259Google Scholar
  66. Hermann V, Büscher R, Go MM, Ring KM, Hofer JK, Kailasam MT, O’Conner DT, Parmer RJ, Insel PA (2000) β2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in Whites and African Americans. Am J Hypertens 13:1021–1026CrossRefPubMedGoogle Scholar
  67. Higashi K, Ishikawa T, Ito T, Yonemura A, Shige H, Nakamura H (1997) Association of a genetic variation in the β3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem Biophys Res Commun 232:728–730CrossRefPubMedGoogle Scholar
  68. Hoffstedt J, Poirier O, Thörne A, Lönnqvist F, Herrmann SM, Cambien F, Arner P (1999) Polymorphism of the human β3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 48:203–205PubMedGoogle Scholar
  69. Hoffstedt J, Iliadou A, Pedersen NL, Schalling M, Arner P (2001) The effect of the beta2 adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol 133:708–712PubMedGoogle Scholar
  70. Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB (2000) Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 139:537–542PubMedGoogle Scholar
  71. Hollenga C, Zaagsma J (1989) Direct evidence for the atypical nature of functional β-adrenoceptors in rat adipocytes. Br J Pharmacol 98:1420–1424PubMedGoogle Scholar
  72. Hopes E, McDougall C, Christie G, Dewar J, Wheatley A, Hall IP, Helms PJ (1998) Association of glutamine 27 polymorphism of β2-adrenoceptor with reported childhood asthma: population based study. Br Med J 316:664Google Scholar
  73. Humma LM, Puckett BJ, Richardson HE, Terra SG, Andrisin TE, Lejeune BL, Wallace MR, Lewis JF, McNamara DM, Picoult-Newberg L, Pepine CJ, Johnson JA (2001) Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 88:1034–1037CrossRefPubMedGoogle Scholar
  74. Ikegami H, Yamato E, Fujisawa T, Hamada Y, Fujioka Y, Rakugi H, Higaki J, Murakami H, Shimamoto K, Ogihara T (1996) Analysis of candidate genes for insulin resistance in essential hypertension. Hypertens Res 19:S31–S34PubMedGoogle Scholar
  75. Inukai T, Tayama K, Inukai Y, Matsutoma R, Takebayashi K, Aso Y, Takemura Y (2001) Clinical features of a polymorphism of the β3-adrenergic receptor gene in patients with type 2 diabetes mellitus—a study using a pin-point sequencing method. Exp Clin Endocrinol Diabetes 109:386–368CrossRefPubMedGoogle Scholar
  76. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K (1999) Association of polymorphisms in the beta2-adrenergic gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 42:98–101CrossRefPubMedGoogle Scholar
  77. Isogaya M, Nagao T, Kurose H (2002) Enhanced cAMP response of naturally occuring mutant of human b3-adrenergic receptor. Jpn J Pharmacol 88:314–318CrossRefPubMedGoogle Scholar
  78. Iwai C, Akita H, Shiga N, Takai E, Miyamoto Y, Shimizu M, Kawai H, Takarada A, Kajiya T, Yokoyama M (2002) Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy. Circ J 66:723–728CrossRefPubMedGoogle Scholar
  79. Janssen JAMJL, Koper JW, Stolk RP, Englaro P, Uitterlinden AG, Huang Q, van Leeuwen JPTM, Blum WF, Attanasio AMF, Pols HAP, Grobbee DE, de Jong FH, Lamberts SWJ (1998) Lack of associations between serum leptin, a polymorphism in the gene for the β3-adrenergic receptor and glucose tolerance in the Dutch population. Clin Endocrinol 49:229–234CrossRefGoogle Scholar
  80. Johnson JA, Terra SG (2002) β-Adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. Pharm Res 19:1779–1787CrossRefPubMedGoogle Scholar
  81. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF (2003) β1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 74:44–52Google Scholar
  82. Joos L, Sandford AJ (2002) Genotype predictors of response to asthma medications. Curr Opin Pulm Med 8:9–15CrossRefPubMedGoogle Scholar
  83. Kanki H, Yang P, Xie HG, Kim RB, George AL Jr, Roden DM (2002) Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome. J Cardiovasc Electrophysiol 13:252–256CrossRefPubMedGoogle Scholar
  84. Kato N, Sugiyama T, Morita H, Kurihara H, Sato T, Yamori Y, Yazaki Y (2001) Association analysis of β2-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 37:286–292PubMedGoogle Scholar
  85. Kaumann AJ, Molenaar P (1997) Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn-Schmiedeberg’s Arch Pharmacol 355:667–681Google Scholar
  86. Kaumann AJ, Engelhardt S, Hein L, Molenaar P, Lohse M (2001) Abolition of (−)-CGP 12177-evoked cardiostimulation in double β1-/β2-adrenoceptor knockout mice. Obligatory role of β1-adrenoceptors for putative β4-adrenoceptor pharmacology. Naunyn-Schmiedeberg’s Arch Pharmacol 363:87–93Google Scholar
  87. Kay LJ, Chong LK, Rostami-Hodjegan A, Peachell PT (2003) Influence of the thr164ile polymorphism in the β2-adrenoceptor on the effects of β-adrenoceptor agonists on human lung mast cells. Int Immunopharmacol 3:91–95CrossRefPubMedGoogle Scholar
  88. Kimura K, Sasaki N, Asano A, Mizukami J, Kayahashi S, Kawada T, Fushiki T, Morimatsu M, Yoshida T, Saito M (2000) Mutated human β3-adrenergic receptor (Trp64Arg) lowers the response to β3-adrenergic agonists in transfected 3T3-L1 preadipocytes. Horm Metab Res 32:91–96PubMedGoogle Scholar
  89. Kiso T, Namikawa T, Tokunaga T, Sawada K, Kakita T, Shogaki T, Ohtsubo Y (1999) Anti-obesity and anti-diabetic activities of a new β3 adrenergic receptor agonist, (S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)]amino]ethyl]-1-propenyl] phenoxy] acetic acid ethanedioic acid (SWR-0342SA), in KK-Ay mice. Biol Pharm Bull 22:1073–1078PubMedGoogle Scholar
  90. Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-Feng Francke U, Caron MG, Lefkowitz RJ (1987) cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 84:46–50PubMedGoogle Scholar
  91. Kortner B, Wolf A, Wendt D, Beisigel U, Evans D (1999) Lack of association between a human beta-2-adrenoceptor gene polymorphism (gln27glu) and morbid obesity. Int J Obes Relat Metab Disord 23:1099–1100CrossRefPubMedGoogle Scholar
  92. Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJL, Skrabal F, Caulfield M (1997) Essential hypertension in African Caribbeans associated with a variant of the β2-adrenoceptor. Hypertension 30:773–776PubMedGoogle Scholar
  93. Krief S, Lonnqvist F, Raimbault S, Baude B, Van Sronson A, Arner P, Strosberg AD, Ricquier D, Emorine LT (1993) Tissue distribution of β3-adrenergic receptor mRNA in man. J Clin Invest 91:344–349PubMedGoogle Scholar
  94. Kurabayashi T, Carey DG, Morrison NA (1996) The β3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 45:1358–1363PubMedGoogle Scholar
  95. Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, Arner P (1997) Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered beta-2 adrenoceptor function. J Clin Invest 100:3005–3013PubMedGoogle Scholar
  96. LaRosee K, Huntgeburth M, Rosenkranz S, Schnabel P (2003) Arg389Gly-Polymorphismus des β1-Adrenozeptors: Unterschiedliche Effekte von Metoprolol in Abhängigkeit vom Genotyp (abstract). Z Kardiol 92 (Suppl):I/191Google Scholar
  97. Levin MC, Marullo S, Muntaner O, Andersson B, Magnusson Y (2002) The myocardium-protective Gly-49 variant of the β1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 277:30429–30435CrossRefPubMedGoogle Scholar
  98. Li LS, Lönnqvist F, Luthman H, Arner P (1996) Phenotypic characterization of the Trp64Arg polymorphism in the beta3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39:857–860CrossRefPubMedGoogle Scholar
  99. Liggett SB (1995) Functional properties of human β2-adrenergic receptor polymorphisms. News Physiol Sci 10:265–273Google Scholar
  100. Liggett SB (1997) Polymorphisms of the β2-adrenergic receptor and asthma. Am J Respir Crit Care Med 156:S156–162PubMedGoogle Scholar
  101. Liggett SB, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC, Walsh RA (1998) The Ile164 β2-adrenergic receptor polymorphisms adversely affects the outcome of congestive heart failure. J Clin Invest 102:1534–1539PubMedGoogle Scholar
  102. Lipworth BJ, Hall IP, Tan S, Aziz I, Coutie W (1999) Effects of genetic polymorphism on ex vivo and in vivo function of β2-adrenoceptors in asthmatic patients. Chest 115:324–328CrossRefPubMedGoogle Scholar
  103. Lipworth B, Koppelman GH, Wheatley AP, Le Jeune I, Coutie W, Meurs H, Kauffman HF, Postma DS, Hall IP (2002) β2-Adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells. Thorax 57:61–66CrossRefPubMedGoogle Scholar
  104. Liu J, Liu Z-Q, Tan Z-R, Chen X-P, Wang L-S, Zhou G, Zhou H-H (2003) Gly389Arg polymorphism of β1-adrenoceptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 74:372–379Google Scholar
  105. Lönnqvist F, Krief S, Strosberg AD, Nyberg S, Emorine LJ, Arner P (1993) Evidence for a functional β3-adrenoceptor in man. Br J Pharmacol 110:929–936PubMedGoogle Scholar
  106. Maqbool A, Hall AS, Ball SG, Balmforth AJ (1999) Common polymorphisms of the β1-adrenoceptor: identification and rapid screening assay. Lancet 353:897Google Scholar
  107. Martin CAE, Advenier C (1995) Beta3-adrenoceptors and airways. Fundam Clin Pharmacol 9:114–118PubMedGoogle Scholar
  108. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R (1997) Association between polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 100:3184–3188PubMedGoogle Scholar
  109. Mason DA, Moore JD, Green SA, Liggett SB (1999) A gain-of-function polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor. J Biol Chem 274:12670–12674PubMedGoogle Scholar
  110. McDevitt DG (1989) In vivo studies on the function of cardiac β-adrenoceptors in man. Eur Heart J 10 (Suppl. B):22–28Google Scholar
  111. McGraw DW, Forbes SL, Kramer LA, Liggett SB (1998) Polymorphisms of the 5′-leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 102:1927–1932PubMedGoogle Scholar
  112. Melis MG, Secchi G, Brizzi P, Severino C, Maioli M, Tonolo G (2002) The Trp64Arg β3-adrenergic receptor amino acid variant confers increased sensitivity to the pressor effects of noradrenaline in Sardinian subjects. Clin Sci 103:397–402PubMedGoogle Scholar
  113. Molenaar P, Rabnott G, Yang I, Fong KM, Savarimuthu SM, Li L, West MJ, Russell FD (2002) Conservation of the cardiostimulant effects of (−)-norepinephrine across Ser49Gly and Gly389Arg beta1-adrenergic receptor polymorphisms in human right atrium in vitro. J Am Coll Cardiol 40:1275–1282Google Scholar
  114. Moore JD, Mason DA, Green SA, Hsu J, Liggett SB (1999) Racial differences in the frequencies of cardiac β1-adrenergic receptor polymorphisms: analysis of c145A→G and c1165G→C (abstract). Human Mutation 14:271CrossRefGoogle Scholar
  115. Moore PE, Laporte JD, Abraham JH, Schwartzman IN, Yandava CN, Silverman ES, Drazen JM, Wand MP, Panettieri RA, Shore SA (2000) Polymorphism of the β2-adrenergic receptor gene and desensitisation in human airway smooth muscle. Am J Respir Crit Care Med 162:2117–2124PubMedGoogle Scholar
  116. Mori Y, Kim-Motoyama H, Ito Y, Katakura T, Yasuda K, Ishiyama-Shigemoto S, Yamada K, Akanuma Y, Ohashi Y, Kimura S, Yazaki Y, Kadowaki T (1999) The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun 258:138–140CrossRefPubMedGoogle Scholar
  117. Oostendorp J, Meurs H, Adriaan-Nelemans S, Zaagsma J, Kauffman HF, Postma DS, Boddecke HWGM, Biber K (2002) Cloning, pharmacological characzterization, and polymorphism screening of the guinea pig β2-adrenoceptor. Eur J Pharmacol 457:1–10CrossRefPubMedGoogle Scholar
  118. O’Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ (2000) The gain-of-function G389R variant of the β1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects. Clin Sci 99:233–238PubMedGoogle Scholar
  119. Parola AL, Kobilka BK (1994) The peptide product of a 5′-leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J Biol Chem 269:4497–4505PubMedGoogle Scholar
  120. Perfetti R, Hui H, Chamie K, Binder S, Seibert M, McLenithan J, Silver K, Walston JD (2001) Pancreatic b-cells expressing the Arg64 variant of the β3-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol 27:133–144PubMedGoogle Scholar
  121. Piétri-Rouxel F, St John Manning B, Gros J, Strosberg AD (1997) The biochemical effect of the naturally occurring Trp64→Arg mutation on human β3-adrenoceptor activity. Eur J Biochem 247:1174–1179PubMedGoogle Scholar
  122. Pihlajamäki J, Rissanen J, Valve R, Heikkinen S, Karjalainen L, Laakso M (1998) Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the β3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia. Metabolism 47:1397–1402PubMedGoogle Scholar
  123. Podlowski S, Wenzel K, Luther HP, Müller J, Bramlage P, Baumann G, Felix SB, Speer A, Hetzer R, Köpke K, Hoehe MR, Wallukat G (2000) β1-Adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 78:87–93CrossRefPubMedGoogle Scholar
  124. Poller U, Fuchs B, Gorf A, Jakubetz J, Radke J, Pönicke K, Brodde O-E (1998) Terbutaline-induced desensitization of human cardiac β2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen. Cardiovasc Res 40:211–222CrossRefPubMedGoogle Scholar
  125. Portillo MP, Rocandio AM, Garcia-Calonge MA, Diaz E, Campo E, Martinez-Blazquez C, Errasti J, del Barrio AS (1995) Lipolytic effects of β1, β2 and β3-adrenergic agonists in isolated human fat cells from omental and retroperitoneal adipose tissues. Rev Esp Fisiol 51:193–200PubMedGoogle Scholar
  126. Pulkkinen A, Kareinen A, Saarinen L, Heikkinen S, Lehto S, Laakso M (1999) The codon 64 polymorphism of the β3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients. Metabolism 48:853–856PubMedGoogle Scholar
  127. Ranade K, Jorgenson E, Sheu WHH, Pei D, Hsiung CA, Chiang F-T, Chen YI, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, Risch N (2002) A polymorphism in the β1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 70:935–942PubMedGoogle Scholar
  128. Rathz DA, Brown KM, Kramer LA, Liggett SB (2002) Amino acid 49 polymorphism of the human β1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 39:155–160CrossRefPubMedGoogle Scholar
  129. Reishaus E, Innis M, MacIntyre N, Liggett SB (1993) Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8:334–339PubMedGoogle Scholar
  130. Ruffolo RR Jr, Spradlin TA, Pollock GD, Waddell JE, Murphy PJ (1981) Alpha and beta adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 219:447–452PubMedGoogle Scholar
  131. Ryden M, Hoffstedt J, Eriksson P, Bringman S, Arner P (2001) The Arg389Gly β1-adrenergic receptor gene polymorphism and human fat cell lipolysis. Int J Obes Relat Metab Disord 25:1599–1603CrossRefPubMedGoogle Scholar
  132. Sandilands AJ, O’Shaughnessy KM, Brown MJ (2003) Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 β1-adrenoceptors versus Gly389 β1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 138:386–392CrossRefPubMedGoogle Scholar
  133. Sarsero D, Russell FD, Lynham JA, Rabnott G, Yang I, Fong KM, Li L, Kaumann AJ, Molenaar P (2003) (−)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the β1-adrenoceptor. Naunyn-Schmiedeberg’s Arch Pharmacol 367:10–21Google Scholar
  134. Scott MG, Swan C, Wheatly AP Hall IP (1999) Identification of novel polymorphisms within the promoter region of the human β2-adrenergic receptor gene. Br J Pharmacol 126:841–844PubMedGoogle Scholar
  135. Shen YT, Zhang H, Vatner F (1994) Peripheral vascular effects of beta-3 adrenoceptor receptor stimulation in conscious dogs. J Pharmacol Exp Ther 268:466–473PubMedGoogle Scholar
  136. Sheu WH, Lee WJ, Yao YE, Jeng CY, Young MM, Chen YT (1999) Lack of association between genetic variation in the β3-adrenergic receptor gene and insulin resistance in patients with coronary heart disease. Metabolism 48:651–654PubMedGoogle Scholar
  137. Shihara N, Yasuda K, Moritani T, Ue H, Adachi T, Tanaka H, Tsuda K, Seino Y (1999) The association between Trp64Arg polymorphism of the β3-adrenergic receptor and autonomic nervous system activity. J Clin Endocrinol Metab 84:1623–627PubMedGoogle Scholar
  138. Shihara N, Yasuda K, Moritani T, Ue H, Uno M, Adachi T, Nunoi K, Seino Y, Yamada Y, Tsuda K (2001) Synergistic effect of polymorphisms of uncoupling protein 1 and β3-adrenergic receptor genes on autonomic nervous system activity. Int J Obes 25:761–766CrossRefGoogle Scholar
  139. Small KM, Forbes SL, Rahman FF, Bridges KM, Liggett SB (2000) A four amino acid deletion polymorphism in the third intracellular loop of the human α2c-adrenergic receptor. J Biol Chem 275:23059–23064CrossRefPubMedGoogle Scholar
  140. Small KM, Wagoner LE, Levin AM, Kardia SLR, Liggett SB (2002) Synergistic polymorphisms of β1- and α2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347:1135–1142Google Scholar
  141. Snitker S, Odeleye OE, Hellmer J, Boschmann M, Monroe MB, Shuldiner AR, Ravussin E (1997) No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue. Diabetologia 40:838–842CrossRefPubMedGoogle Scholar
  142. Sofowora GG, Dishy V. Muszkat M, Xie HG, Kim RB, Harris PA, Prasad HC, Byrne DW, Nair UB, Wood AJJ, Stein CM (2003) A common β1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β-blockade. Clin Pharmacol Ther 73:366–371CrossRefPubMedGoogle Scholar
  143. Stangl K, Cascorbi I, Laule M, Stangl V, Meisel C, Wernecke KD, Ziemer S, Baumann G, Roots I, Hauner H (2001) The β3-adrenergic receptor Trp64Arg mutation is not associated with coronary artery disease. Metabolism 50:184–188CrossRefPubMedGoogle Scholar
  144. Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G, Barbato A, D’Elia L, Trevisan M, Farinaro E (2001) Relationship of the Trp64Arg polymorphism of the β3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 19:399–406PubMedGoogle Scholar
  145. Strosberg AD (1997) Association of β3-adrenoceptor polymorphism with obesity and diabetes: current status. Trends Pharmacol Sci 18:449–454PubMedGoogle Scholar
  146. Summerhill E, Leavitt SA, Gidley H, Parry R, Solway J, Ober C (2000) β2-Adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites. Am J Respir Crit Care Med 162:599–602PubMedGoogle Scholar
  147. Susulic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper ME, Himms-Hagen J, Flier JS, Lowell BB (1995) Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem 270:29483–29492CrossRefPubMedGoogle Scholar
  148. Tamaki S, Iwai N, Tsujita Y, Nakamura Y, Ohmichi N, Kinoshita M (1999) Variant of the β3-adrenergic receptor gene and coronary atherosclerosis in Japanese subjects. Int J Cardiol 69:309–311CrossRefPubMedGoogle Scholar
  149. Tesson F, Charron P, Peuchmaurd M, Nicaud V, Cambien F, Tiret L, Poirier O, Desnis M, Jullieres Y, Amouyel P, Roizes G, Dorent R, Schwartz K, Komajda M, for the CARDIGENE group (1999) Characterization of a unique genetic variant of the β1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 31:1025–1032PubMedGoogle Scholar
  150. Thomas RF, Liggett SB (1993) Lack of β3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol Pharmacol 43:343–348PubMedGoogle Scholar
  151. Thomas GN, Tomlinson B, Chan JC, Young RP, Critchley JA (2000) The Trp64Arg polymorphism of the β3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord 24:545–551CrossRefPubMedGoogle Scholar
  152. Timmermann B, Mo R, Luft FC, Gerdts E, Busjahn A, Omvik P, Li G-H, Schuster H, Wienker TF, Hoehe MR, Lund-Johansen P (1998) β2-Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: the Bergen Blood Pressure Study. Kidney Int 53:1455–1460PubMedGoogle Scholar
  153. Tonolo G, Melis MG, Secchi G, Atzeni MM, Angius MF, Carboni A, Ciccarese M, Malavasi A, Maioli M (1999) Association of Trp64Arg β3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. J Hypertens 17:33–38CrossRefPubMedGoogle Scholar
  154. Turki J, Pak J, Green S, Martin R, Liggett SB (1995) Genetic polymorphisms of the β2-adrenergic receptor in nocturnal and non-nocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 95:1635–1641PubMedGoogle Scholar
  155. Turki J, Lorenz JN, Green SA, Donnelly ET, Jacinto M, Liggett SB (1996) Myocardial signalling defects and impaired cardiac function of a human β2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci USA 93:10483–10488CrossRefPubMedGoogle Scholar
  156. Ulbrecht M, Hergeth MT, Wjst M, Heinrich J, Bickeböller, Wichmann H-E, Weiss EH (2000) Association of β2-adrenoceptor variants with bronchial hyperresponsiveness. Am J Respir Crit Care Med 161:469–474PubMedGoogle Scholar
  157. Umekawa T, Yoshida T, Sakane N, Kogure A, Kondo M, Honjyo H (1999) Trp64Arg mutation of β3-adrenoceptor gene deteriorates lipolysis induced by β3-adrenoceptor agonist in human omental adipocytes. Diabetes 48:117–120PubMedGoogle Scholar
  158. Urhammer SA, Clausen JO, Hansen T, Pedersen O (1996) Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the β3-adrenergic receptor gene. Diabetes 45:1115–1120PubMedGoogle Scholar
  159. Urhammer SA, Hansen T, Borch-Johnsen K, Pedersen O (2000) Studies of the synergistic effect of the Trp/Arg64 polymorphism of the β3-adrenergic receptor gene and the −3826 A→G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a population-based sample of 379 young Danish subjects. J Clin Endocrinol Metab 85:3151–3154Google Scholar
  160. Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, Abraham WT, Chenier TC, Dorn GW, Liggett SB (2000) Polymorphisms of the β2-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 86:834–840PubMedGoogle Scholar
  161. Wagoner LE, Craft LL, Zengel P, McGuire N, Rathz DA, Dorn GW 2nd, Liggett SB (2002) Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 144:840–846CrossRefPubMedGoogle Scholar
  162. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg AD, Stern MP, Raben N, Sorkin JD, Roth J, Shuldiner AR (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor gene. N Engl J Med 333:343–347PubMedGoogle Scholar
  163. Weir TD, Mallek N, Sandford AJ, Bai TR, Awadh N, FitzGerald JM, Cockcroft D, James A, Liggett SB, Paré PD (1998) β2 Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 158:787–791PubMedGoogle Scholar
  164. White HL, Maqbool A, McMahon AD, Yates L, Ball SG, Hall AS, Balmforth AJ (2002) An evaluation of the beta-1 adrenergic receptor ARg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy. Eur Heart J 23:1087–1092CrossRefPubMedGoogle Scholar
  165. Widén E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC (1995) Association of a polymorphism in the β3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348–351PubMedGoogle Scholar
  166. Wilson C, Wilson S, Piercy V, Sennitt MV, Arch JR (1984) The rat lipolytic β-adrenoceptor: studies using novel β-adrenoceptor agonists. Eur J Pharmacol 100:309–319CrossRefPubMedGoogle Scholar
  167. Xie H-G, Stein CM, Kim RB, Gainer JV, Sofowora G, Dishy V, Brown NJ, Goree RE, Haines JL, Wood AJJ (2000) Human β2-adrenergic receptor polymorphisms: no association with essential hypertension in black and white Americans. Clin Pharmacol Ther 67:670–675CrossRefPubMedGoogle Scholar
  168. Xie H-G, Dishy V, Sofowora G, Kim RB, Landau R, Smiley RM, Zhou H-H, Wood AJJ, Harris P, Stein CM (2001) Arg389Gly [beta]1-adrenoceptor polymorphism varies in frequency among different ethic groups but does not alter response in vivo. Pharmacogenetics 11:191–197CrossRefPubMedGoogle Scholar
  169. Yamada K, Ishiama-Shigemoto S, Ichikawa F, Yuan X, Koyanagi A, Koyama W, Nonaka K (1999) Polymorphism in the 5′-leader cistron of the β2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab 84:1754–1757PubMedGoogle Scholar
  170. Zilberfarb V, Piétri-Rouxel F, Jockers R, Krief S, Delouis C, Issad T, Strosberg AD (1997) Human immortalized brown adipocytes express functional β3-adrenoceptor coupled to lipolysis. J Cell Sci 110:801–807PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • K. Leineweber
    • 1
  • R. Büscher
    • 2
  • H. Bruck
    • 1
  • O.-E. Brodde
    • 1
  1. 1.Depts. of Pathophysiology and NephrologyUniversity of Essen School of Medicine, IG I., 9.OGEssenGermany
  2. 2.Department of Pediatric NephrologyUniversity of Essen School of MedicineEssenGermany

Personalised recommendations